Results 21 to 30 of about 169,700 (260)

Multiple sclerosis and COVID-19

Biomedical Papers, 2020
This paper reviews currently available data on the novel coronavirus and clinical features of COVID-19, followed by a detailed section on possible modifications of immunomodulatory therapy in multiple sclerosis patients with COVID-19, based on what we ...
Jan Mares, Hans-Peter Hartung
doaj   +1 more source

Immunomodulatory Therapy for Ischemic Heart Disease. [PDF]

Circulation
Ischemic heart disease is a leading cause of death worldwide, manifested clinically as myocardial infarction (and ischemic cardiomyopathy. Presently, there exists a notable scarcity of efficient interventions to restore cardiac function after myocardial infarction.
Zhao X, Williamson T, Gong Y, Epstein JA, Fan Y.   +4 more
europepmc   +4 more sources

Pharmaco-Immunomodulatory Therapy in COVID-19 [PDF]

Drugs, 2020
The severe acute respiratory syndrome coronavirus 2 associated coronavirus disease 2019 (COVID-19) illness is a syndrome of viral replication in concert with a host inflammatory response. The cytokine storm and viral evasion of cellular immune responses may play an equally important role in the pathogenesis, clinical manifestation, and outcomes of ...
Rizk, John G., Kalantar-Zadeh, Kamyar, Mehra, Mandeep R., Lavie, Carl J., Rizk, Youssef, Forthal, Donald N.   +5 more
openaire   +6 more sources

Clinical and immunological efficacy of immunotherapeutic program after surgical treatment of children with various forms of acute peritonitis

Медицинская иммунология, 2022
Acute peritonitis (AP) is among the most frequent and severe conditions in pediatric abdominal surgery. Due to development of antibiotic resistance and increasing number of atypical infectious and inflammatory diseases (IIDs), a lot of specialists ...
I. V. Nesterova, G. A. Chudilova, V. N. Chapurina, S. V. Kovaleva, Yu. V. Teterin, N. K. Barova, D. E. Lyagusha, V. A. Tarakanov   +7 more
doaj   +1 more source

Immunomodulatory Therapy for MIS-C

Pediatrics, 2023
CONTEXT Studies comparing initial therapy for multisystem inflammatory syndrome in children (MIS-C) provided conflicting results. OBJECTIVE To compare outcomes in MIS-C patients treated with intravenous immunoglobulin (IVIG), glucocorticoids, or the
Ouldali, Naïm, Son, Mary Beth F., Mcardle, Andrew, Vito, Ortensia, Vaugon, Esther, Belot, Alexandre, Leblanc, Claire, Murray, Nancy, Patel, Manish, Levin, Michael, Randolph, Adrienne, Angoulvant, François   +11 more
openaire   +4 more sources

The immunomodulatory effects of antihypertensive therapy: A review

Biomedicine & Pharmacotherapy, 2022
Hypertension remains the leading preventable risk factor for stroke and coronary artery disease, significantly contributing to all-cause global mortality and predisposing patients to renal and heart failure, as well as peripheral vascular disease. Due to the widespread usage of antihypertensive drugs, global mean blood pressure has remained unchanged ...
Dominik, Felkle, Mateusz, Jarczyński, Konrad, Kaleta, Katarzyna, Zięba, Katarzyna, Nazimek   +4 more
openaire   +2 more sources

Immunomodulatory therapies for acute pancreatitis

World Journal of Gastroenterology, 2014
It is currently difficult for conventional treatments of acute pancreatitis (AP), which primarily consist of anti-inflammatory therapies, to prevent the progression of AP or to improve its outcome. This may be because the occurrence and progression of AP, which involves various inflammatory cells and cytokines, includes a series of complex immune ...
Jing, Li, Wen-Juan, Yang, Lu-Ming, Huang, Cheng-Wei, Tang   +3 more
openaire   +2 more sources

Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis [PDF]

, 2021
AbstractHypercholesterolemia is a major risk factor in atherosclerosis development and lipid-lowering drugs (i.e., statins) remain the treatment of choice. Despite effective reduction of LDL cholesterol in patients, a residual cardiovascular risk persists in some individuals, highlighting the need for further therapeutic intervention.
Justine, Deroissart, Florentina, Porsch, Thomas, Koller, Christoph J, Binder   +3 more
openaire   +2 more sources

The Role of Chemotherapy in Pediatric Myoepithelial Carcinoma: A Systematic Review of the Literature

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Myoepithelial carcinoma (MEC) in pediatric patients is a rare and aggressive malignancy characterized by heterogeneous morphology and variable molecular features. The optimal role of chemotherapy remains unclear. We conducted a systematic review according to PRISMA 2020 guidelines to evaluate chemotherapy in pediatric and young‐adult patients ...
Marco Salvi, Maria Carmen Affinita, Giulia Fichera, Luisa Santoro, Angela Scagnellato, Calogero Virgone, Elena Poli, Gianni Bisogno   +7 more
wiley   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source